Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer

Nature Medicine
K D BuntingB P Sorrentino

Abstract

Janus kinase-3 (JAK3) deficiency has recently been identified as a cause of severe combined immunodeficiency (SCID) in humans. We used a mouse model of Jak3-deficient SCID to test a gene therapy approach for treatment of this disease. Transfer of a Jak3 retroviral vector to repopulating hematopoietic stem cells resulted in increased numbers of T and B lymphocytes, reversal of hypogammaglobulinemia, restoration of T-cell activation upon stimulation with mitogens, and development of an antigen-specific immune response after immunization. Analysis for vector copy number in lymphoid and myeloid populations showed a large in vivo selective advantage for Jak3-expressing lymphoid cells. These results show that gene replacement is a feasible treatment strategy for this disease and that naturally occurring in vivo selection of corrected cells is an important advantage of this approach.

References

Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D M BodineA W Nienhuis
Aug 1, 1986·Molecular and Cellular Biology·A D Miller, C Buttimore
Nov 3, 1995·Science·T NosakaJ N Ihle

❮ Previous
Next ❯

Citations

Dec 5, 2002·International Journal of Hematology·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Mar 15, 2002·Current Allergy and Asthma Reports·F Candotti
Feb 24, 2001·Ryōikibetsu shōkōgun shirīzu·S Kumaki, S Tsuchiya
Oct 15, 1998·Nature Medicine·J A AllayB P Sorrentino
Jan 14, 1998·Nature Medicine·C Bordignon
Nov 2, 2004·Nature Reviews. Immunology·Brian P Sorrentino
Nov 25, 2000·Clinical and Experimental Immunology·A Fischer
Feb 18, 1999·The New England Journal of Medicine·A Fischer
Apr 19, 2002·The New England Journal of Medicine·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Jul 13, 2000·Human Gene Therapy·S Halene, D B Kohn
Apr 14, 1999·Australian and New Zealand Journal of Medicine·M P Brown
Jun 18, 1999·Annals of the New York Academy of Sciences·T WhitwamJ M Puck
Jan 3, 2001·Molecular and Cellular Biology·R WenJ L Cleveland
Apr 18, 2000·Journal of Clinical Pathology·A M Jones, H B Gaspar
Apr 25, 2000·Annual Review of Medicine·R ParkmanD Kohn
Jan 22, 2005·Annual Review of Medicine·Marina Cavazzana-CalvoAlain Fischer
Nov 5, 2005·Blood·Tobias NeffHans-Peter Kiem
Apr 29, 2008·Blood·Arthur W Nienhuis
Aug 28, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Makoto Otsu, Fabio Candotti
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·K D BuntingB P Sorrentino
Feb 4, 2014·International Journal of Hematology·Fabio Candotti
Jan 18, 2011·Hematology/oncology Clinics of North America·Alain FischerM Cavazzana-Calvo
May 12, 2009·Advanced Drug Delivery Reviews·Anna M WagnerDaniel Surbek
Apr 19, 2008·Seminars in Fetal & Neonatal Medicine·Daniel SurbekAnna Wagner
Jan 22, 2005·Immunological Reviews·Alain FischerMarina Cavazzana-Calvo
Jan 22, 2005·Immunological Reviews·Marko PesuJohn J O'Shea
Dec 29, 2000·Pediatric Clinics of North America·F Candotti
Sep 10, 2013·Seminars in Hematology·Andre Larochelle, Cynthia E Dunbar
Feb 6, 2003·Cytotherapy·E M HorwitzM Dominici
Mar 6, 1999·Molecular Genetics and Metabolism·P Mora-Garcia, K M Sakamoto
Apr 26, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hatem ZayedBruce R Blazar
Oct 13, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Biying XuDavid W Scott
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·M OtsuF Candotti
Aug 30, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·N SawaiBrian P Sorrentino
Oct 23, 2001·Human Mutation·L D NotarangeloR F Schumacher
Jun 3, 2000·Nature Medicine·R H Buckley
Dec 11, 1999·Current Opinion in Pediatrics·Y MinegishiM E Conley
May 23, 2001·Leukemia·V F Van TendelooZ N Berneman

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.